# Whitehawk Therapeutics, Inc.: Form 8-K, filed Nov 6, 2024

- Company: [Whitehawk Therapeutics, Inc.](/companies/whwk.md) (CIK 1422142)
- Form: 8-K
- Filed: 2024-11-06
- Accepted by EDGAR: Nov 6, 2024, 08:05 ET
- Period: 2024-11-06
- Accession: 0001628280-24-045465
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1422142/000162828024045465/aadi-20241106.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1422142/000162828024045465/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1422142/000162828024045465/aadi-20241106.htm

Filed Nov 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-045465. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.
